47 related articles for article (PubMed ID: 32930121)
21. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
Zhang X; Tian T; Sun W; Liu C; Fang X
Medicine (Baltimore); 2017 Jun; 96(26):e7346. PubMed ID: 28658153
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
23. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li S; Lai Y; Fan J; Shen C; Che G
Clin Exp Med; 2017 May; 17(2):161-174. PubMed ID: 27099933
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.
Xie SS; Li M; Zhou CC; Song XL; Wang CH
PLoS One; 2014; 9(7):e103431. PubMed ID: 25072281
[TBL] [Abstract][Full Text] [Related]
28. Role of gross tumor volume in the prognosis of non-small cell lung cancer treated with 3D conformal radiotherapy: a meta-analysis.
Yu Y; Guan H; Xing LG; Xiang YB
Clin Ther; 2015 Oct; 37(10):2256-66. PubMed ID: 26293808
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
Hu M; Hu Y; He J; Li B
PLoS One; 2016; 11(1):e0147374. PubMed ID: 26824699
[TBL] [Abstract][Full Text] [Related]
31. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
33. KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.
Ying M; Zhu XX; Zhao Y; Li DH; Chen LH
Asian Pac J Cancer Prev; 2015; 16(10):4439-45. PubMed ID: 26028111
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Dammeijer F; Lievense LA; Veerman GD; Hoogsteden HC; Hegmans JP; Arends LR; Aerts JG
J Clin Oncol; 2016 Sep; 34(26):3204-12. PubMed ID: 27432922
[TBL] [Abstract][Full Text] [Related]
35. Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials.
Soo RA; Loh M; Mok TS; Ou SH; Cho BC; Yeo WL; Tenen DG; Soong R
J Thorac Oncol; 2011 Jun; 6(6):1030-8. PubMed ID: 21532500
[TBL] [Abstract][Full Text] [Related]
36. The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Yang Y; Xian L
Tumour Biol; 2014 Apr; 35(4):2905-21. PubMed ID: 24338713
[TBL] [Abstract][Full Text] [Related]
37. EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer: a meta-analysis.
Zhang Q; Dai HH; Dong HY; Sun CT; Yang Z; Han JQ
Lung Cancer; 2014 Sep; 85(3):339-45. PubMed ID: 25043903
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
39. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
40. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.
Yang M; Shen H; Qiu C; Ni Y; Wang L; Dong W; Liao Y; Du J
Eur J Cancer; 2013 Feb; 49(3):604-15. PubMed ID: 23099007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]